April 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountrevlimid.com
Global Rank
#4,422,333
583,537Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
42.91%
Pages per Visit
1.69
Avg Visit Duration
00:00:26
- Company
- - -
- Industry
- - -
Top 10 revlimid.com Competitors
The Top 10 Sites Like revlimid.com in April 2026 are ranked by their affinity to revlimid.com in terms of keyword traffic, audience targeting, and market overlap
important safety information warning: embryo-fetal toxicity and venous thromboembolism embryo-fetal toxicity if thalidomide is taken during pregnancy, it can cause severe birth defects or embryo-fetal death. thalidomide should never be used by females who are pregnant or who could become pregnant while taking the drug. even a single dose [1 capsule (regardless of strength)] taken by a pregnant woman during her pregnancy can cause severe birth defects because of this toxicity and in an effort to make the chance of embryo-fetal exposure to thalomid® (thalidomide) as negligible as possible, thalomid® (thalidomide) is approved for marketing only through a special restricted distribution program: thalomid rems® program, approved by the food and drug administration you can get the information about thalomid and the thalomid rems® program on the internet at www.celgeneriskmanagement.com or by calling the manufacturer's toll-free number 1-888-423-5436 venous thromboembolism the use of thalomid (thalidomide) in multiple myeloma results in an increased risk of venous thromboembolism, such as deep venous thrombosis and pulmonary embolism. this risk increases significantly when thalidomide is used in combination with standard chemotherapeutic agents including dexamethasone. in one controlled trial, the rate of venous thromboembolism was 22.5% in patients receiving thalidomide in combination with dexamethasone compared to 4.9% in patients receiving dexamethasone alone (p = 0.002). patients and physicians are advised to be observant for the signs and symptoms of thromboembolism. instruct patients to seek medical care if they develop symptoms such as shortness of breath, chest pain, or arm or leg swelling. consider thromboprophylaxis based on an assessment of individual patients’ underlying risk factors contraindications pregnancy: see boxed warnings. thalomid can cause fetal harm when administered to a pregnant female. thalomid is contraindicated in females who are pregnant. thal
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
100%The FDA is responsible for protecting and promoting the public health
- Company
- FDA
- Industry
- Health > Pharmacy
Bounce Rate
57.63%
Pages per Visit
2.77
Avg Visit Duration
00:02:28
Similarity Score
91%Explore POMALYST® (pomalidomide) treatment, a prescription medication used to treat adults. See Safety Info & Boxed WARNINGS on birth defects and blood clots.
- Company
- - -
- Industry
- - -
Global Rank
#9,373,010
1,765,383Bounce Rate
38.54%
Pages per Visit
1.41
Avg Visit Duration
00:00:04
Similarity Score
85%Transforming cancer care through innovative medicines, pioneering research & patient-first approach. Explore our pipeline, therapies & commitment.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
84%Patch innovation in CINV Prevention. Sancuso® is the only FDA-approved transdermal patch for chemotherapy-induced nausea and vomiting
- Company
- - -
- Industry
- - -
Global Rank
#9,596,512
4,069,507Bounce Rate
35.46%
Pages per Visit
1.28
Avg Visit Duration
00:00:05
Similarity Score
83%breakthrough science. one moment, one day, one person at a time.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
81%Learn more about ADCETRIS. See Important Safety Information, including BOXED WARNING, and Important Facts.
- Company
- - -
- Industry
- - -
Global Rank
#1,297,665
1,000,738Bounce Rate
63%
Pages per Visit
1.70
Avg Visit Duration
00:02:17
Similarity Score
80%learn about canasa (mesalamine) 1000 mg rectal suppository, a prescription medicine used to treat adults with mildly to moderately active ulcerative proctitis. view safety and full prescribing information, read disease information, and access patient resources.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
80%for more than a century, merck has been inventing medicines and vaccines for many of the world's most challenging diseases. we have always been and always will be inventing, and we do it for the single greatest purpose: life.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
80%phn treatment – gralise (gabapentin) tablets
- Company
- - -
- Industry
- - -
Global Rank
#5,986,100
1,073,635Bounce Rate
40.34%
Pages per Visit
1.62
Avg Visit Duration
00:00:28
Similarity Score
80%revlimid.com's top 5 competitors in April 2026 are: thalomid.com, fda.gov, pomalyst.com, velcade.com, and more.
According to Similarweb data of monthly visits, revlimid.com’s top competitor in April 2026 is thalomid.com. revlimid.com 2nd most similar site is fda.gov, and closing off the top 3 is pomalyst.com.
velcade.com ranks as the 4th most similar website to revlimid.com and sancuso.com ranks fifth in April 2026.
The other five competitors in the top 10 list are tarceva.com, adcetris.com, canasa.com, invanz.com, and gralise.com.